Faculty members share insights, expertise on the ramifications of a decline in federal support for science and research ...
The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...
Grant funding uncertainty has jeopardized the sustainability of research projects and discouraged researchers.
The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.
These are the Cincinnati Children's Hospital Medical Center and the Research Institute at Nationwide Children’s Hospital in ...
If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...